ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 155 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $67,764 | -8.7% | 23,367 | +3.2% | 0.00% | 0.0% |
| Q4 2022 | $74,233 | -9.5% | 22,632 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $82,000 | -50.9% | 21,575 | +0.6% | 0.00% | -50.0% |
| Q2 2022 | $167,000 | -11.6% | 21,445 | +5.6% | 0.00% | 0.0% |
| Q1 2022 | $189,000 | -38.2% | 20,315 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $306,000 | -12.1% | 19,390 | -0.4% | 0.00% | -33.3% |
| Q3 2021 | $348,000 | +16.0% | 19,467 | +0.8% | 0.00% | +50.0% |
| Q2 2021 | $300,000 | -2.9% | 19,319 | -10.1% | 0.00% | -33.3% |
| Q1 2021 | $309,000 | -23.1% | 21,492 | +5.0% | 0.00% | -25.0% |
| Q4 2020 | $402,000 | +51.1% | 20,472 | -0.2% | 0.00% | +33.3% |
| Q3 2020 | $266,000 | +18.8% | 20,519 | +33.7% | 0.00% | 0.0% |
| Q2 2020 | $224,000 | +130.9% | 15,349 | +34.2% | 0.00% | +50.0% |
| Q1 2020 | $97,000 | – | 11,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |